Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker: Cellarity, Alloy and more
As venture capital pours into budding biotechs, we're launching the Fierce Biotech Fundraising Tracker to keep tabs on all things financing.
Max Bayer
,
Gabrielle Masson
Oct 4, 2022 10:00am
Flagship-founded Cellarity closes $121M series C round
Oct 4, 2022 7:00am
Rivus raises $132M series B as metabolic pipeline heats up
Sep 22, 2022 10:41am
Starry syndicate powers $165M bet on in vivo CAR-T therapies
Sep 14, 2022 8:15am
Acelyrin brings total raised in 1 year past past $500M mark
Sep 13, 2022 10:05am
Pfizer among investors raising Nimbus $125M for phase 3 launch
Sep 12, 2022 11:00am
